1. Completed
Loading page
Mainboard
Mainboard issue. Listed.
Source: IPO Guru Pro
Company information, issue size, price band, lot size, minimum investment, and the dates published for this issue.
Ami Organics Limited was incorporated in 2004. It develops and makes advanced pharmaceutical intermediates for regulated and generic APIs and new chemical entities, and key starting materials for agrochemical and fine chemicals, helped by its acquisition of the business of Gujarat Organics. It has developed and commercialised over 450 pharma intermediates across 17 key therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. It is one of the major makers of intermediates for APIs such as Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. It supplies more than 150 customers in India and 25 countries, including Laurus Labs, Cadila Healthcare and Cipla. Its three plants at Sachin, Ankleshwar and Jhagadia in Gujarat have an installed capacity of 6,060 MTPA. The IPO was Rs 569.64 crore, with Rs 200.00 crore of fresh issue and Rs 369.64 crore of offer for sale. Rs 140.00 crore was planned for repaying borrowings and Rs 90.00 crore for working capital.
Current premium in rupees, the derived percentage, and the indicative price. History shows observed readings only. A missing premium is unavailable, not ₹0.
Grey Market Premium (GMP) is an unofficial market indicator and is not published by stock exchanges. Estimated listing values are illustrative, may change, and should not be considered a forecast or investment recommendation.
Subscription is shown in times subscribed. A missing multiple stays unavailable. A published zero is 0x.
Last updated: Unavailable
Last updated: Unavailable
Source: IPO Guru Pro Data by IPO Guru
History retrieved: 10 Nov 2026, 4:30 PM IST
No day-wise subscription history is loaded. Missing days are left blank and are not plotted as zero.
Source: IPO Guru Pro. History retrieved 10 Nov 2026, 4:30 PM IST.
Revenue and profit are in rupees for each reporting period. Assets, liabilities, and ratios use the source unit when the statement includes them. Missing figures stay blank.
| Metric (Rs. Crore) | 31 Mar 2021 | 31 Mar 2020 | 31 Mar 2019 |
|---|---|---|---|
| Assets | 413.27 | 231.89 | 213.15 |
| Total Income | 341.99 | 242.49 | 238.90 |
| Profit After Tax | 54.00 | 27.47 | 23.30 |
Results may still be pending. Check Allotment opens the registrar allotment portal. You may need to select this IPO there. Sign-in is not required.
This is the actual change from the issue price to the listing price. It is separate from the unofficial GMP estimate. A missing price stays unavailable.
RHP, DRHP, and other links that passed the official address check. Unverified addresses are left out.
Data by IPO Guru · Updated
Ami Organics is an R&D driven maker of advanced pharmaceutical intermediates for APIs and new chemical entities, and of materials for agrochemicals and fine chemicals. Its total income was Rs 341.99 crore in FY2021.
Nareshkumar Ramjibhai Patel, Chetankumar Chhaganlal Vaghasia, Shital Nareshbhai Patel and Parul Chetankumar Vaghasia
1. Completed
2. Completed
3. Completed
4. Completed
Refund
Demat credit
Indicative only. A GMP-implied price is not a guaranteed listing price.
Unofficial grey-market premium in rupees. Missing observations are not connected and are not drawn as ₹0. This chart is not the listing gain.
High unavailable · Low unavailable
Tap a point for its rupee amount, percentage, and IST time. The table lists the same observations.
Source: IPO Guru Pro. History retrieved 10 Nov 2026, 4:30 PM IST.
| Observed (IST) | GMP (₹) | GMP % | Mark |
|---|---|---|---|
| 13 Sept 2021, 12:00 PM IST | ₹150 | +24.59% | None |
No intraday GMP history is loaded. Missing slots are not filled in.
High unavailable · Low unavailable
Source: IPO Guru Pro. History retrieved 10 Nov 2026, 4:30 PM IST.
| EBITDA | 80.15 | 41.02 | 42.08 |
| NET Worth | 166.93 | 111.81 | 82.22 |
| Reserves and Surplus | 135.43 | 101.31 | 71.72 |
| Total Borrowing | 136.64 | 59.42 | 53.90 |